Around a core strength in pharmaceutical sector IP, Olivares has built a substantial and wider-reaching practice across life sciences in Mexico, representing an outstanding choice in rights protection, but also being reliable counsel for a range of commercial matters in the related industries. On the regulatory side, life sciences research and development projects are a standout strength, and the practice has been a fixture in matters that have shaped Mexico’s pharmaceuticals regulatory framework. The aforementioned IP expertise of the firm bears fruit in its patent work, including patent term corrections and patent linkage, while on the trade mark side, the firm has innovated a database system of the Mexican Trademark Office and regulatory agency COFEPRIS that predicts whether a drug will gain the authorisation of its commercial name. Administrative compliance is a further strength, while in transactional matters the team has become increasingly well versed in assisting with the development, consolidation, and expansion of its clients' Mexican operations. Gustavo Alcocer oversees the corporate, transactional and financing aspects of the practice; Alejandro Luna excels in litigation, with standout expertise in patent matters; Armando Arenas heads the anti-piracy/counterfeiting practice in medicines, while also leading on civil litigation matters; and Rommy Morales is a specialist in patent prosecution, IP litigation, and plant variety protection. The above-mentioned lawyers jointly coordinate the life sciences practice as a whole. Further names to note include senior associates Ingrid Ortiz and Karla Olvera, who both excel in litigation; and Mauricio Samano, a patent expert.
Legal 500 redaktioneller Kommentar

Auszeichnungen

Mandantenzufriedenheit

Referenzen

Unabhängig vom Legal 500-Forschungsteam zusammengestellt.

  • ‘Without a doubt, Olivares has always stood out for being an innovative firm in the pharmaceutical sector. They always think about how to help companies and obtain innovative resolutions that serve as a spearhead to recognize important rights of companies.'

Kernmandanten

  • Roche
  • Biogen
  • GSK
  • Novartis
  • Lilly
  • Abbvie
  • Sanofi
  • Pfizer
  • Astellas
  • Anheuser-Busch InBev

Anwält*innen

Führende Partner*innen

Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.

Alejandro Luna

Führende Associates

Führende Associates sind regelmäßig an zentralen Mandaten des Teams beteiligt und erhalten positives Feedback von Wettbewerbern oder Mandanten.

Karla Olvera
Ingrid Ortiz

Praxisleitung

Gustavo Alcocer; Alejandro Luna; Armando Arenas; Rommy Morales